# Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/modified-xeliri-capecitabine-plus-irinotecan-versus-folfiri-leucovorin/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Rui‐Hua Xu,Kei Muro,Satoshi Morita,Satoru Iwasa,Sae Won Han,Wei Wang,Masahito Kotaka,Masato Nakamura,Joong Bae Ahn,Yan‐Hong Deng,Takeshi Kato,Sang‐Hee Cho,Yi Ba,Hiroshi Matsuoka,Keun‐Wook Lee,Tao Zhang,Yasuhide Yamada,Junichi Sakamoto,Young Suk Park,Tae Won Kim |
| Citations | 164 |
| DOI | 10.1016/s1470-2045(18)30140-2 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2792494514 |
| PMID | 29555258 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Wei Wang](https://scholariq.org/researchers/wei-wang-4/)
- [Takeshi Kato](https://scholariq.org/researchers/takeshi-kato/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.